IWA
GILD icon

Icon Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Icon Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-989
Closed -$111K – 524
2025
Q1 		$111K Sell
989
-502
-34% -$51.8K 0.01% 461
2024
Q4 		$138K Buy
1,491
+38
+3% +$3.42K 0.01% 447
2024
Q3 		$122K Buy
1,453
+28
+2% +$2.14K 0.01% 437
2024
Q2 		$108K Sell
1,425
-2,292
-62% -$153K 0.01% 424
2024
Q1 		$272K Buy
3,717
+455
+14% +$35K 0.03% 299
2023
Q4 		$264K Buy
+3,262
New +$254K 0.03% 282
2022
Q4 		$276K Sell
3,214
-379
-11% -$30K 0.03% 264
2022
Q3 		$222K Buy
+3,593
New +$227K 0.03% 280

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Icon Wealth Advisors's GILD Position: Q2 2025 in Review

Icon Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 989 shares — an estimated $111K sold.

Icon Wealth Advisors first reported a position in GILD in Q3 2022 and held it in 8 quarters. The position peaked at $276K in Q4 2022. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Icon Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Icon Wealth Advisors sold 989 Gilead Sciences shares in Q2 2025, an estimated $111K.
  • Icon Wealth Advisors first reported a position in Gilead Sciences in Q3 2022 and held it in 8 quarters.
  • Icon Wealth Advisors's Gilead Sciences position peaked at $276K in Q4 2022.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Icon Wealth Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.